More reads

• Contract drug manufacturer Catalent to buy Paragon Bioservices in $1.2 billion deal (Wall Street Journal)
• Researchers want to link your genes and income. Should they? (Wired)
• Gene-edited babies: What a Chinese scientist told an American mentor (New York Times)